Skip to main content
Caplight Logo









Novobeing

Novobeing

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://novobeing.com/

Last Round

Strategic

Dec 3, 2024

Company Overview

Novobeing is a digital health company that provides a therapeutic VR platform to reduce stress, anxiety, and pain.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, AR/VR Experiences, Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Freemium

AI Layer

Application

Keywords

therapeutic VRVR therapydigital therapeuticsDTxstress reductionpain managementanxiety reliefdigital mental healthnon-pharmacological therapyclinically validated VRVR hardware bundleenterprise healthcareVR meditationVR breathworkpatient engagementMeta Quest platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novobeing Comparables

Compare Novobeing with similar companies based on industry and business-model similarity.

Novobeing comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Virtual Therapeutics
85%
TRIPP, Inc.
84%
Healium
83%

Novobeing Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 3, 2024
AcceleratorApr 30, 2024
SeedFeb 1, 2024

Key People

Founding team and executive leadership

Sid Desai

Co-Founder & CEO

Founding Team

Novobeing Investors

Notable investors and investment history

Novobeing investors
InvestorRounds
Roux InstituteAccelerator
Maine Venture FundAccelerator
ImpactAssetsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2024

    Raised a strategic round with participation from Ted Schilowitz.

  • Apr 30, 2024

    $50K raised from Roux Institute and others.

Novobeing Filings

Explore SEC and related filing metadata, where available.

Novobeing filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novobeing's valuation, stock price, and market status.

Is Novobeing a public or private company?

Novobeing is a private company.

What is the current stock price of Novobeing?

Novobeing is a private company with no public stock price. No recent secondary market data is available.

How much is Novobeing worth (valuation)?

Valuation information for Novobeing is not publicly available.

Can I buy Novobeing stock?

Novobeing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novobeing's last funding round?

Novobeing's most recent funding round was Strategic on December 3, 2024.

Who are the main investors in Novobeing?

Key investors in Novobeing include Roux Institute, Maine Venture Fund, ImpactAssets.

Will Novobeing IPO soon?

No public IPO plans have been announced for Novobeing.

How can I track Novobeing secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novobeing's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range6
Year Founded2020
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?